DOKTER CELESTIN - PAJOTA MEDICAL & CLINICAL RESEARCH CENTER
0672.692.723 · rovalta.com · 28/09/2026
ACTIVE
DOKTER CELESTIN - PAJOTA MEDICAL & CLINICAL RESEARCH CENTER
Financial year 2024 · Closed on 31/12/2024
Net result21,5 k €-78,4 %over 1 year
Gross margin71 k €-67,2 %over 1 year
Equity527,3 k €+4,3 %over 1 year
Overview
Identity
Source · BCE/KBODOKTER CELESTIN - PAJOTA MEDICAL & CLINICAL RESEARCH CENTER is a Private company with limited liability incorporated in 2017. Its registered office is in Sint-Pieters-Leeuw.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0672.692.723
- Incorporation
- 15/03/2017
- Legal form
- Private company with limited liability
- Registered office
- Brusselbaan 293
1600 Sint-Pieters-Leeuw · FlandreSee on map - Contributed capital
- 14 920,00 €
- Latest accounts
- 31/12/2024
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 8 filingsTrend over 8 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 71 k € | -67.2% | 216,8 k € | +1.4% | 213,7 k € | +28.8% | 165,9 k € | +21.0% | 137,1 k € |
| EBITDA | 70,2 k € | -67.5% | 216,1 k € | +1.7% | 212,5 k € | +28.5% | 165,4 k € | +21.4% | 136,2 k € |
| Operating result | 40,3 k € | -78.4% | 186,6 k € | +1.9% | 183,1 k € | +31.9% | 138,8 k € | +16.5% | 119,1 k € |
| Net result | 21,5 k € | -78.4% | 100 k € | -20.5% | 125,7 k € | +89.3% | 66,4 k € | -25.1% | 88,7 k € |
| Balance sheet | |||||||||
| Equity | 527,3 k € | +4.3% | 505,8 k € | +24.6% | 405,8 k € | +44.9% | 280,1 k € | +31.1% | 213,7 k € |
| Total assets | 669,9 k € | -11.3% | 755,1 k € | +14.8% | 657,5 k € | +18.5% | 554,8 k € | +52.5% | 363,8 k € |
| Cash | 522 k € | -5.4% | 551,7 k € | +3.5% | 533,1 k € | +43.1% | 372,4 k € | +57.8% | 236 k € |
| Debts | 142,5 k € | -42.8% | 249,4 k € | +1.1% | 246,7 k € | -7.6% | 267,1 k € | +81.7% | 146,9 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/12/20241 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
CELESTIN FOKOUAMOUAFO | Directorsince 10/03/2017Managersince 10/03/2017ended |
Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/10/2025 | 04/11/2024 | 10/10/2023 | 18/10/2022 | 21/02/2022 | 19/01/2021 |
| General meeting | 30/10/2025 | 31/10/2024 | 10/10/2023 | 06/10/2022 | 17/02/2022 | 30/11/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 8 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2024 | 30/10/2025 | 31/10/2025 | Dutch | |
| Micro model | 31/12/2023 | 31/10/2024 | 04/11/2024 | Dutch | |
| Micro model | 31/12/2022 | 10/10/2023 | 10/10/2023 | Dutch | |
| Micro model | 31/12/2021 | 06/10/2022 | 18/10/2022 | Dutch | |
| Micro model | 31/12/2020 | 17/02/2022 | 21/02/2022 | Dutch | |
| Micro model | 31/12/2019 | 30/11/2020 | 19/01/2021 | French | |
| Micro model | 31/12/2018 | 27/06/2019 | 03/10/2019 | Dutch | |
| Micro model | 31/12/2017 | 02/03/2019 | 04/03/2019 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20241 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
CELESTIN FOKOUAMOUAFO | Directorsince 10/03/2017Managersince 10/03/2017ended |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other17/03/2017RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings8 filings
Mandates
CELESTIN FOKOUAMOUAFO
2017201820192020202120222023202420252026
PMRC
Brusselbaan 293, 1600 Sint-Pieters-Leeuw
Director
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Brusselbaan 293, 1600 Sint-Pieters-LeeuwCurrent | accounts 2021 → 2024 | Accounts 2024 · 2025-00559676 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| DOKTER CELESTIN - PAJOTA MEDICAL & CLINICAL RESEARCH CENTERCurrent | CBE | |
| PMRC | accounts 2021 → 2024 | Accounts 2024 · 2025-00559676 |
Events
- 2024Annual accounts 202421,5 k €↓
- 2023Annual accounts 2023100 k €↓
- 2022Annual accounts 2022125,7 k €↑
- 2021Annual accounts 202166,4 k €↓
- 2020Annual accounts 202088,7 k €↑
- 2019Annual accounts 201930,8 k €↓
- 2018Annual accounts 201833,8 k €↓
- 2017Annual accounts 201745,4 k €
- 15/03/2017IncorporationPrivate company with limited liability